NT PHARMA 01011Hong Kong Stock Exchange

0.4002.44%( -0.010 )
Oct 13 · End-of-day data, not live · Hong Kong Stock Exchange
NT PHARMA (01011) Company Profile - Company Info, Industry & Management - cibo

Company Information

Market
HKEX Main Board
Listing Date
2011-04-20
Industry
Innovative Drugs & Biologics
Fiscal Year End
Dec 31
ISIN
KYG2114L1133

Industry

Innovative Drugs & Biologics 1.67%
124 stocks in this industry
Down 80 Up 33
Industry RankingsValue (HKD)Rank
Revenue (Last FY)28.32M104/112
Net Profit (Last FY)-30.53M60/125

Change is the 2026-10-13 close against the previous close; the industry change is the equal-weighted average of its stocks. Sub-industry classification is maintained by cibo. Last FY is each company's latest annual report. Net profit is profit attributable to owners of the parent; ROE = net profit / closing equity attributable to owners. Non-HKD statements are converted at ECB reference rates.

Management

NamePosition
NG Tit Executive Director
NG Anna Ching Mei Executive Director
QIAN Wei Non-Executive Director
CHIN Yu Non-Executive Director
Lou Yongbin Non-Executive Director
YU Tze Shan Hailson Independent Non-Executive Director
ZHAO Yubiao Independent Non-Executive Director
Kwok Che Chung Independent Non-Executive Director

Board list from the HKEXnews "List of Directors and their Role and Function", as of 2026-05-12.

About this page

This page shows NT PHARMA (01011) company information, related securities, the price change distribution and in-industry rankings within its sub-industry, and the board of directors. Quotes come from HKEX Daily Quotations, financial metrics from each company's latest annual report, and the director list from HKEXnews.